FDA: PROC MIXED (‼) for ABE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-17 17:15 (940 d 21:41 ago) – Posting: # 22581
Views: 2,552

Hi Mahmoud,

❝ I think that using proc mixed to fit RTR/TRR/RRT design is not suitable, because in most cases proc mixed produced Estimated G matrix is not positive definite.


❝ So proc GLM recommended by FDA and Emea is more appropriate in the Semi-replicated designs


Please read the entire thread again. The FDA does recommend PROC MIXED for ABE in all guidances.
That’s the problem.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,983 posts in 4,822 threads, 1,648 registered users;
36 visitors (0 registered, 36 guests [including 7 identified bots]).
Forum time: 14:56 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5